Research Groups and R&D Platforms: Antibacterial

Research Group:
Gas and biosensors

Jouko Peltonen
jouko.peltonen[at]abo.fi

Laboratory of physical chemistry,
Åbo Akademi University

Jouko Peltonen

Antibacterial, Antibodies, Assay development, Atomic-force microscopy, Diagnostics, Electron microscopy, Formulation, In Vitro Diagnostics, Inflammation, Molecular diagnostics, Nanoparticles, Organic compounds, Particle size analysis, Personalized medicine, Pharmacy, Physico-chemical properties, Point of care, Porosity, Surface area, Zeta potential

Research Group:
FUNCELL

Carl-Eric Wilen
cwilen[at]abo.fi

Department of Chemical Engineering,
Åbo Akademi University

Carl-Eric Wilen

FUNMAT

 

Antibacterial, Antibodies, Bacteriology, Biochemistry, Biomolecular chemistry, Biotechnology, Chemical Physics, FTIR or RAMAN spectroscopy, Imaging, In Vitro Diagnostics, MALS or SEC-MALS, NMR, Organic compounds, Particle size analysis, Physico-chemical properties, Surface area, Synthetic chemistry, Thermal analysis

Research Group:
Biofilm-host –interaction in chronic infection

Riikka Ihalin
riikka.ihalin[at]utu.fi

Department of Life Technologies,
University of Turku

Riikka Ihalin

Antibacterial, Bacteriology, Basic research, Biochemistry, Biomedicine, Biomolecular chemistry, Dentistry, Disease models, Drug target, Electron microscopy, Fluorescence spectroscopy, Imaging, Immunology, Infection, Inflammation, Molecular Biology, Molecular Cell Biology, NMR, Proteomics, Receptor, Signaling, Structural Biology, Target discovery, X-ray crystallography

Research Group:
Molecular epidemiology, carriage and antimicrobial susceptibility of bacterial pathogens

Jaana Vuopio
jaana.vuopio[at]utu.fi

Institute of Biomedicine,
University of Turku

Jaana Vuopio

Antibacterial, Antibodies, Bacteriology, Basic research, Bioinformatics, Biomarker, Biomedicine, Clinical Medicine, Data mining, Diagnostics, Epidemiology, Genetics, Genomics, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Infection, Inflammation, Molecular diagnostics, Next-generation sequencing, Nucleic acids, Personalized medicine, Point of care, Receptor